InvestorsHub Logo
Followers 4
Posts 702
Boards Moderated 0
Alias Born 05/19/2016

Re: plexrec post# 111347

Saturday, 07/15/2017 3:01:10 PM

Saturday, July 15, 2017 3:01:10 PM

Post# of 474310
From the abstract:

"an ongoing Phase 2a clinical trial in Alzheimer’s Disease demonstrates dose dependent cognitive IMPROVEMENTS."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News